- Home
- INBX vs OPRX Comparison
INBX vs OPRX Comparison
Compare INBX & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- OPRX
- Stock Information
- Founded
- INBX 2010
- OPRX 2006
- Country
- INBX United States
- OPRX United States
- Employees
- INBX N/A
- OPRX N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- OPRX Business Services
- Sector
- INBX Health Care
- OPRX Consumer Discretionary
- Exchange
- INBX Nasdaq
- OPRX Nasdaq
- Market Cap
- INBX 430.2M
- OPRX 380.6M
- IPO Year
- INBX 2020
- OPRX N/A
- Fundamental
- Price
- INBX $78.51
- OPRX $19.61
- Analyst Decision
- INBX Hold
- OPRX Buy
- Analyst Count
- INBX 2
- OPRX 8
- Target Price
- INBX N/A
- OPRX $12.19
- AVG Volume (30 Days)
- INBX 680.2K
- OPRX 253.5K
- Earning Date
- INBX 11-14-2025
- OPRX 11-06-2025
- Dividend Yield
- INBX N/A
- OPRX N/A
- EPS Growth
- INBX N/A
- OPRX N/A
- EPS
- INBX N/A
- OPRX N/A
- Revenue
- INBX $1,400,000.00
- OPRX $104,748,000.00
- Revenue This Year
- INBX $563.00
- OPRX $17.92
- Revenue Next Year
- INBX $230.77
- OPRX $10.91
- P/E Ratio
- INBX N/A
- OPRX N/A
- Revenue Growth
- INBX N/A
- OPRX 25.89
- 52 Week Low
- INBX $10.81
- OPRX $3.78
- 52 Week High
- INBX $83.78
- OPRX $22.25
- Technical
- Relative Strength Index (RSI)
- INBX 84.62
- OPRX 50.90
- Support Level
- INBX $28.16
- OPRX $18.43
- Resistance Level
- INBX $39.27
- OPRX $21.56
- Average True Range (ATR)
- INBX 5.72
- OPRX 1.21
- MACD
- INBX 4.49
- OPRX 0.01
- Stochastic Oscillator
- INBX 90.52
- OPRX 36.39
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.